These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 7515764

  • 1. Uterotrophic actions of estradiol and tamoxifen are associated with inhibition of uterine insulin-like growth factor binding protein 3 gene expression.
    Huynh H, Pollak M.
    Cancer Res; 1994 Jun 15; 54(12):3115-9. PubMed ID: 7515764
    [Abstract] [Full Text] [Related]

  • 2. Insulin-like growth factor I gene expression in the uterus is stimulated by tamoxifen and inhibited by the pure antiestrogen ICI 182780.
    Huynh HT, Pollak M.
    Cancer Res; 1993 Dec 01; 53(23):5585-8. PubMed ID: 8242606
    [Abstract] [Full Text] [Related]

  • 3. Estrogen and selective estrogen receptor modulator regulation of insulin-like growth factor binding protein 5 in the rat uterus.
    Andrade PM, Silva ID, Borra RC, Lima GR, Baracat EC.
    Gynecol Endocrinol; 2002 Aug 01; 16(4):265-70. PubMed ID: 12396554
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780.
    Chan TW, Pollak M, Huynh H.
    Clin Cancer Res; 2001 Aug 01; 7(8):2545-54. PubMed ID: 11489838
    [Abstract] [Full Text] [Related]

  • 5. Suppression of uterine insulin-like growth factor binding protein 5 by estrogen is mediated in part by insulin-like growth factor I.
    Huynh H.
    Int J Oncol; 1998 Feb 01; 12(2):427-32. PubMed ID: 9458371
    [Abstract] [Full Text] [Related]

  • 6. Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells.
    Sheikh MS, Shao ZM, Hussain A, Clemmons DR, Chen JC, Roberts CT, LeRoith D, Fontana JA.
    J Cell Physiol; 1993 Jun 01; 155(3):556-67. PubMed ID: 7684042
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors.
    McCarthy TL, Casinghino S, Centrella M, Canalis E.
    J Cell Physiol; 1994 Jul 01; 160(1):163-75. PubMed ID: 7517403
    [Abstract] [Full Text] [Related]

  • 9. Post-transcriptional and post-translational regulation of insulin-like growth factor binding protein-3 and -4 by insulin-like growth factor-I in uterine myometrial cells.
    Huynh H.
    Growth Horm IGF Res; 2000 Feb 01; 10(1):20-7. PubMed ID: 10753589
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Expression of insulin-like growth factor binding protein-4, insulin-like growth factor-I receptor, and insulin-like growth factor-I in the mouse uterus throughout the estrous cycle.
    Henemyre C, Markoff E.
    Mol Reprod Dev; 1999 Apr 01; 52(4):350-9. PubMed ID: 10092114
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Potential mechanism of estrogen-mediated decrease in bone formation: estrogen increases production of inhibitory insulin-like growth factor-binding protein-4.
    Kassem M, Okazaki R, De León D, Harris SA, Robinson JA, Spelsberg TC, Conover CA, Riggs BL.
    Proc Assoc Am Physicians; 1996 Mar 01; 108(2):155-64. PubMed ID: 8705735
    [Abstract] [Full Text] [Related]

  • 14. Protooncogene, growth factor, growth factor receptor, and estrogen and progesterone receptor gene expression in the immature rat uterus after treatment with estrogen and tamoxifen.
    Bhattacharyya N, Ramsammy R, Eatman E, Hollis VW, Anderson WA.
    J Submicrosc Cytol Pathol; 1994 Apr 01; 26(2):147-62. PubMed ID: 8019941
    [Abstract] [Full Text] [Related]

  • 15. Lack of synergy between estrogen and progesterone on local IGF-I, IGFBP-3 and IGFBP-2 secretion by both hormone-dependent and hormone-independent breast cancer explants in vitro. Effect of tamoxifen and mifepristone (RU 486).
    Milewicz T, Gregoraszczuk EL, Sztefko K, Augustowska K, Krzysiek J, Ryś J.
    Growth Horm IGF Res; 2005 Apr 01; 15(2):140-7. PubMed ID: 15809018
    [Abstract] [Full Text] [Related]

  • 16. In vivo inhibition of insulin-like growth factor I gene expression by tamoxifen.
    Huynh HT, Tetenes E, Wallace L, Pollak M.
    Cancer Res; 1993 Apr 15; 53(8):1727-30. PubMed ID: 8467486
    [Abstract] [Full Text] [Related]

  • 17. Dietary quercetin does not affect pituitary lutenizing hormone (LH) expression and has no uterotropic effects in ovariectomized Sprague-Dawley rats.
    Rachoń D, Vortherms T, Seidlová-Wuttke D, Jarry H, Wuttke W.
    Food Chem Toxicol; 2008 Feb 15; 46(2):513-8. PubMed ID: 17905502
    [Abstract] [Full Text] [Related]

  • 18. Regulation of gene expression by 8-prenylnaringenin in uterus and liver of Wistar rats.
    Diel P, Thomae RB, Caldarelli A, Zierau O, Kolba S, Schmidt S, Schwab P, Metz P, Vollmer G.
    Planta Med; 2004 Jan 15; 70(1):39-44. PubMed ID: 14765291
    [Abstract] [Full Text] [Related]

  • 19. IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells.
    Fleming JM, Leibowitz BJ, Kerr DE, Cohick WS.
    J Endocrinol; 2005 Jul 15; 186(1):165-78. PubMed ID: 16002546
    [Abstract] [Full Text] [Related]

  • 20. Expression of insulin-like growth factors and their binding proteins in the estrogen responsive Ishikawa human endometrial cancer cell line.
    Hana V, Murphy LJ.
    Endocrinology; 1994 Dec 15; 135(6):2511-6. PubMed ID: 7527333
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.